Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) Interest Expenses (2023 - 2026)

Adagio Medical Holdings has reported Interest Expenses over the past 4 years, most recently at $778000.0 for Q1 2026.

  • Quarterly Interest Expenses rose 17.52% to $778000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, up 62.74% year-over-year, with the annual reading at $2.9 million for FY2025, 162.99% up from the prior year.
  • Interest Expenses was $778000.0 for Q1 2026 at Adagio Medical Holdings, roughly flat from $775000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $778000.0 in Q1 2026 and troughed at $435000.0 in Q3 2024.
  • The 4-year median for Interest Expenses is $734500.0 (2025), against an average of $669500.0.
  • The largest YoY upside for Interest Expenses was 72.18% in 2025 against a maximum downside of 12.2% in 2025.
  • A 4-year view of Interest Expenses shows it stood at $577000.0 in 2023, then fell by 24.61% to $435000.0 in 2024, then skyrocketed by 78.16% to $775000.0 in 2025, then rose by 0.39% to $778000.0 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Interest Expenses are $778000.0 (Q1 2026), $775000.0 (Q4 2025), and $749000.0 (Q3 2025).